Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshiki Niimi

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Journal of Community Genetics|January 15, 2024
Advertisement by medical facilities as an opportunity route of APOE genetic testing in Japan: a website analysisKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
JAR Life|February 3, 2026
Prediction of one-year cognitive decline via self-perceived memory in older adults during the COVID-19 pandemicKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Journal of Alzheimer'S Disease : JAD|October 9, 2025
Property difference in Mini-Mental State Examination Serial Sevens and World Backwards: Analysis using item response theoryKenichiro Sato, Ryoko Ihara, Yoshiki Niimi, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 11, 2025
Blood-based biomarker prescreening with different testing combinations and cutoffs: A simulation study examining efficacy and cost-effectiveness in Alzheimer's disease prevention studiesKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Journal of Alzheimer'S Disease : JAD|June 27, 2026
Potential and biases of large language model simulation for public surveys on Alzheimer's disease therapiesKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
JAR Life|February 3, 2026
Utility of APOE testing for reducing ARIA under probabilistic stopping rates to treat with anti-amyloid therapy for ε4-homozygote patients: A simulation studyKenichiro Sato, Yoshiki Niimi, Masanori Kurihara, et al.
Journal of Alzheimer'S Disease : JAD|May 17, 2024
Simplifying Alzheimer's Disease Monitoring: A Novel Machine-Learning Approach to Estimate the Clinical Dementia Rating Sum of Box Changes Using the Mini-Mental State Examination and Functional Activities QuestionnaireKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|December 23, 2021
Species-specific accumulation of ceramides in cerebrospinal fluid from encephalomyeloradiculoneurpathy patients associated with peripheral complement activation: A pilot studyTatsuro Mutoh, Yoshiki Niimi, Shota Sakai, et al.
Journal of Alzheimer'S Disease : JAD|February 10, 2025
Cognitive function instrument-based anosognosia to predict amyloid statusYuichiro Furuya, Kenichiro Sato, Yoshiki Niimi, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Journal of Community Genetics|January 15, 2024
Advertisement by medical facilities as an opportunity route of APOE genetic testing in Japan: a website analysisKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
JAR Life|February 3, 2026
Prediction of one-year cognitive decline via self-perceived memory in older adults during the COVID-19 pandemicKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Journal of Alzheimer'S Disease : JAD|October 9, 2025
Property difference in Mini-Mental State Examination Serial Sevens and World Backwards: Analysis using item response theoryKenichiro Sato, Ryoko Ihara, Yoshiki Niimi, et al.
Alzheimer'S & Dementia (New York, N. Y.)|March 11, 2025
Blood-based biomarker prescreening with different testing combinations and cutoffs: A simulation study examining efficacy and cost-effectiveness in Alzheimer's disease prevention studiesKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Journal of Alzheimer'S Disease : JAD|June 27, 2026
Potential and biases of large language model simulation for public surveys on Alzheimer's disease therapiesKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
JAR Life|February 3, 2026
Utility of APOE testing for reducing ARIA under probabilistic stopping rates to treat with anti-amyloid therapy for ε4-homozygote patients: A simulation studyKenichiro Sato, Yoshiki Niimi, Masanori Kurihara, et al.
Journal of Alzheimer'S Disease : JAD|May 17, 2024
Simplifying Alzheimer's Disease Monitoring: A Novel Machine-Learning Approach to Estimate the Clinical Dementia Rating Sum of Box Changes Using the Mini-Mental State Examination and Functional Activities QuestionnaireKenichiro Sato, Yoshiki Niimi, Ryoko Ihara, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|December 23, 2021
Species-specific accumulation of ceramides in cerebrospinal fluid from encephalomyeloradiculoneurpathy patients associated with peripheral complement activation: A pilot studyTatsuro Mutoh, Yoshiki Niimi, Shota Sakai, et al.
Journal of Alzheimer'S Disease : JAD|February 10, 2025
Cognitive function instrument-based anosognosia to predict amyloid statusYuichiro Furuya, Kenichiro Sato, Yoshiki Niimi, et al.
Pageof 8